Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves In Vivo Efficacy and Tolerability.

Goldberg SD, Satomaa T, Aina O, Aitio O, Burke K, Dudkin V, Geist B, Irrechukwu O, Hänninen AL, Heiskanen A, Helin J, Hiltunen JO, Kinyamu-Akunda J, Klein DM, Kohli N, Kotiranta T, Lähteenmäki T, Niemelä R, Pitkänen V, Pynnönen H, Rittase W, Wiley K, Zhou J, Saarinen J

Open source

DOI: 10.1158/1535-7163.mct-23-0591
Published: 2024 Nov 4
Container: Molecular cancer therapeutics
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/1535-7163.mct-23-0591,
  title = {Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves In Vivo Efficacy and Tolerability.},
  author = {Goldberg SD and Satomaa T and Aina O and Aitio O and Burke K and Dudkin V and Geist B and Irrechukwu O and Hänninen AL and Heiskanen A and Helin J and Hiltunen JO and Kinyamu-Akunda J and Klein DM and Kohli N and Kotiranta T and Lähteenmäki T and Niemelä R and Pitkänen V and Pynnönen H and Rittase W and Wiley K and Zhou J and Saarinen J},
  year = {2024},
  journal = {Molecular cancer therapeutics},
  doi = {10.1158/1535-7163.mct-23-0591},
  url = {https://doi.org/10.1158/1535-7163.mct-23-0591}
}

RIS

TY  - JOUR
TI  - Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves In Vivo Efficacy and Tolerability.
AU  - Goldberg SD
AU  - Satomaa T
AU  - Aina O
AU  - Aitio O
AU  - Burke K
AU  - Dudkin V
AU  - Geist B
AU  - Irrechukwu O
AU  - Hänninen AL
AU  - Heiskanen A
AU  - Helin J
AU  - Hiltunen JO
AU  - Kinyamu-Akunda J
AU  - Klein DM
AU  - Kohli N
AU  - Kotiranta T
AU  - Lähteenmäki T
AU  - Niemelä R
AU  - Pitkänen V
AU  - Pynnönen H
AU  - Rittase W
AU  - Wiley K
AU  - Zhou J
AU  - Saarinen J
PY  - 2024
JO  - Molecular cancer therapeutics
DO  - 10.1158/1535-7163.mct-23-0591
UR  - https://doi.org/10.1158/1535-7163.mct-23-0591
ER  -

APA

SD, G., T, S., O, A., O, A., K, B., V, D., B, G., O, I., AL, H., A, H., J, H., JO, H., J, K., DM, K., N, K., T, K., T, L., R, N., V, P., H, P., W, R., K, W., J, Z., & J, S. (2024). Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves In Vivo Efficacy and Tolerability.. Molecular cancer therapeutics. https://doi.org/10.1158/1535-7163.mct-23-0591

Source records

pubmed · retrieved 2026-09-27T00:04:58.309Z
europe-pmc · retrieved 2026-09-27T00:04:58.323Z